4
Total investments
0
Early stage
1
Mid stage
0
Late stage
27y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2016
Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publicly-traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.
Experience · 7 entries
All (7)
Investments (4)
Founder (3)
Board (4)
2016
Co-Founder & Chief Business Officer
Mar 2016
iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development.
Imprint: https://iomx.com/imprint
Board Member
Jan 2016
Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publicly-traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.
2009
Board Member
Jul 2009
Vetter is a global leader in the aseptic filling and packaging of injectable pharmaceutical and biotech compounds with over 40 years of experience and dozens of novel product approvals. We offer highly specialized, state-of-the-art parenteral manufacturing expertise for the entire life cycle, from clinical development to commercial production.
Our focus is supporting our customers’ success. Our unique blend of expertise in development, clinical trial manufacturing, commercial manufacturing, lyophilization, labeling and packaging technologies provides customers with the strategic partnership that can accelerate their compound’s success. We look at a project from every angle to help our customers find solutions that achieve their goals.
We are a family-owned, independent company with facilities in both Germany and the US. Our commitment to sustainability, compliance and social responsibility extends well beyond regulation and represents the very core of what we stand for.
Vetter Development Service:
Development services and clinical trial manufacturing from preclinical through Phase III
Vetter Commercial Manufacturing:
Aseptic manufacturing from Phase III through global market launch
Vetter Packaging Solutions:
Drug delivery systems and packaging services
Privacy Notice: https://www.vetter-pharma.com/en/privacy-notice
Imprint: https://www.vetter-pharma.com/en/imprint
1999
G
GATC BIOTECH AG
Board Member
Dec 1999
G
GATC BIOTECH AG
Board Member
Dec 1999
Show all 7 entries ↓
Investment activity
1999–2016 · 4 investments
Recent (last 2 years)Earlier
Similar investors
Biotechnology investors in Germany
Investor lists
Lists that match Elmar's portfolio
- Angel investors in Germany875 investors
- Biotechnology investors in Germany260 investors
- Manufacturing investors in Germany369 investors
- Startup investors in Germany2,001 investors






